Live Breaking News & Updates on Geert Kersten

Stay updated with breaking news from Geert kersten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results

CEL-SCI Corporation today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments.

Clinical and Corporate Developments. ....

United States , Geert Kersten , Securities Exchange , European Union , Drug Administration , Exchange Commission , European Medicines Agency Paediatric Committee , Corporate Developments , Registration Study , European Medicines Agency , Paediatric Committee , Leukocyte Interleukin , Orphan Drug , Securities Act , Securities Exchange Act ,

CEL-SCI Corp (CVM) Receives FDA Go-Ahead for Confirmatory Study of Multikine

CEL-SCI Corp (CVM) Receives FDA Go-Ahead for Confirmatory Study of Multikine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Geert Kersten , Drug Administration , Leukocyte Interleukin , Registration Study ,

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

CEL-SCI Corporation today announced the appointment of Mario Gobbo to its Board of Directors.

Mr. Gobbo has nearly 40 years of banking and corporate finance experience in healthcare and energy.. ....

United States , Ocimum Genelogic , Mario Gobbo , Geert Kersten , Securities Exchange , European Bank , Exchange Commission , Natixis Bleichroeder Inc , International Finance Corporation , Wharton School Of The University Pennsylvania , Harvard College , Swiss Bank Corporation , World Bank , University Of Colorado , Natixis Bleichroeder , Norganic Chemistry , Business Economics , Wharton School , Wall Street , Leukocyte Interleukin , Orphan Drug , Securities Act , Securities Exchange Act ,

CEL-SCI Corp (CVM) Appoints Mario Gobbo to Its Board

CEL-SCI Corp (CVM) Appoints Mario Gobbo to Its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Ocimum Genelogic , Geert Kersten , Mario Gobbo , Wharton School Of The University Pennsylvania , Harvard College , International Finance Corporation , World Bank , Swiss Bank Corporation , European Bank , Natixis Bleichroeder Inc , University Of Colorado , Natixis Bleichroeder , Norganic Chemistry , Business Economics , Wharton School , Wall Street ,

CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug

CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Geert Kersten , Securities Exchange , Product Service , International Society For Pharmaceutical Engineering , Exchange Commission , International Conference For Harmonization , Its Multikine Manufacturing Facility , Commercial Scale Production , Neck Cancer , Leukocyte Interleukin , Biologics License Application , Master Plan , International Society , Pharmaceutical Engineering , International Conference , Orphan Drug , Securities Act , Securities Exchange Act , Annual Report ,